Origins of life: first came evolutionary dynamics
QRB Discovery · 2023 · 4
DOI: 10.1017/qrd.2023.2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift QRB Discovery, online erschienen am 22.03.2023. Verfasst von Charles Kocher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
When life arose from prebiotic molecules 3.5 billion years ago, what came first? Informational molecules (RNA, DNA), functional ones (proteins), or something else? We argue here for a different logic: rather than seeking a molecule type , we seek a dynamical process. Biology required an ability to evolve before it could choose and optimise materials. We hypothesise that the evolution process was rooted in the peptide folding process. Modelling shows how short random peptides can collapse in water and catalyse the elongation of others, powering both increased folding stability and emergent autocatalysis through a disorder-to-order process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, USA.
- Department of Physics and Astronomy, Stony Brook University, Stony Brook, NY, USA.
- Department of Chemistry, Stony Brook University, Stony Brook, NY, USA.
ORCID-Profile: Charles Kocher, Ken A Dill
Zitieren
APA
Kocher, C., & Dill, K. A. (2023). Origins of life: first came evolutionary dynamics. QRB Discovery, 4. https://doi.org/10.1017/qrd.2023.2
Vancouver
Kocher C, Dill KA. Origins of life: first came evolutionary dynamics. QRB Discovery. 2023;4. doi:10.1017/qrd.2023.2
BibTeX
@article{Kocher2023,
author = {Kocher, Charles and Dill, Ken A},
title = {Origins of life: first came evolutionary dynamics},
journal = {QRB Discovery},
year = {2023},
volume = {4},
doi = {10.1017/qrd.2023.2}
}
EUVIMED